01 1Dipharma Francis S.r.l.
01 1Sodium Neridronate
01 1Italy
NDC Package Code : 46438-0673
Start Marketing Date : 2026-02-12
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
58
PharmaCompass offers a list of Neridronate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Neridronate manufacturer or Neridronate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neridronate manufacturer or Neridronate supplier.
A Neridronate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neridronate, including repackagers and relabelers. The FDA regulates Neridronate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neridronate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Neridronate supplier is an individual or a company that provides Neridronate active pharmaceutical ingredient (API) or Neridronate finished formulations upon request. The Neridronate suppliers may include Neridronate API manufacturers, exporters, distributors and traders.
click here to find a list of Neridronate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Neridronate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Neridronate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Neridronate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Neridronate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Neridronate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Neridronate suppliers with NDC on PharmaCompass.
